001     153166
005     20240229123040.0
024 7 _ |a 10.1002/ijc.32870
|2 doi
024 7 _ |a pmid:31945199
|2 pmid
024 7 _ |a 0020-7136
|2 ISSN
024 7 _ |a 1097-0215
|2 ISSN
024 7 _ |a altmetric:74143402
|2 altmetric
037 _ _ |a DKFZ-2020-00219
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Jakszyn, P.
|0 0000-0003-0672-8847
|b 0
245 _ _ |a Inflammatory potential of the diet and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
260 _ _ |a Bognor Regis
|c 2020
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1597748268_9712
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2020 Aug 15;147(4):1027-1039
520 _ _ |a Pro-inflammatory diets are associated with risk of developing colorectal cancer (CRC), however inconsistencies exist in subsite- and sex-specific associations. The relationship between CRC and combined lifestyle-related factors that contribute towards a low-grade inflammatory profile has not yet been explored. We examined the association between the dietary inflammatory potential and an inflammatory profile and CRC risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. This cohort included 476,160 participants followed-up of 14 years and 5,991 incident CRC cases (3,897 colon and 2,094 rectal tumours). Dietary inflammatory potential was estimated using an Inflammatory Score of the Diet (ISD). An Inflammatory Profile Score (IPS) was constructed, incorporating the ISD, physical activity level and abdominal obesity. The associations between the ISD and CRC and IPS and CRC were assessed using multivariable regression models. More pro- inflammatory diets were related to a higher CRC risk, particularly for colon cancer; Hazar Ratio (HR) for highest versus lowest ISD quartile was 1.15 (95% confidence interval (CI) 1.04-1.27) for CRC, 1.24 (95% CI 1.09-1.41) for colon cancer and 0.99 (95% CI 0.83-1.17) for rectal cancer. Associations were more pronounced in men and not significant in women. The IPS was associated with CRC risk, particularly colon cancer among men; HRs for the highest versus lowest IPS were 1.62 (95% CI 1.31- 2.01) for colon cancer overall and 2.11 (95% CI 1.50-2.97) for colon cancer in men. This study shows that more pro-inflammatory diets and a more inflammatory profile are associated with higher risk of CRC, principally colon cancer and in men. This article is protected by copyright. All rights reserved.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Cayssials, V.
|b 1
700 1 _ |a Buckland, G.
|b 2
700 1 _ |a Perez-Cornago, A.
|b 3
700 1 _ |a Weiderpass, E.
|0 0000-0003-2237-0128
|b 4
700 1 _ |a Boeing, H.
|b 5
700 1 _ |a Bergmann, M. M.
|b 6
700 1 _ |a Vulcan, A.
|b 7
700 1 _ |a Ohlsson, B.
|b 8
700 1 _ |a Masala, G.
|b 9
700 1 _ |a Cross, A. J.
|b 10
700 1 _ |a Riboli, E.
|b 11
700 1 _ |a Ricceri, F.
|0 0000-0001-8749-9737
|b 12
700 1 _ |a Dahm, C.
|b 13
700 1 _ |a Nyvang, D.
|b 14
700 1 _ |a Katzke, V. A.
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 15
|u dkfz
700 1 _ |a Kühns, T.
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Kyrø, C.
|0 0000-0002-9083-8960
|b 17
700 1 _ |a Tjønneland, A.
|b 18
700 1 _ |a Ward, H. A.
|0 0000-0002-2721-2404
|b 19
700 1 _ |a Tsilidis, K. K.
|0 0000-0002-8452-8472
|b 20
700 1 _ |a Skeie, G.
|b 21
700 1 _ |a Sieri, S.
|0 0000-0001-5201-172X
|b 22
700 1 _ |a Sanchez, M. J.
|b 23
700 1 _ |a Huerta, J. M.
|b 24
700 1 _ |a Amiano, P.
|b 25
700 1 _ |a Lasheras, C.
|b 26
700 1 _ |a Ardanaz, E.
|b 27
700 1 _ |a Mahamat-Saleh, Y.
|b 28
700 1 _ |a Boutron-Ruault, M. C.
|0 0000-0002-5956-5693
|b 29
700 1 _ |a Carbonnel, F.
|b 30
700 1 _ |a Panico, S.
|b 31
700 1 _ |a Peppa, E.
|b 32
700 1 _ |a Trichopoulou, A.
|b 33
700 1 _ |a Karakatsani, A.
|b 34
700 1 _ |a Tumino, R.
|b 35
700 1 _ |a Vermeulen, R.
|b 36
700 1 _ |a Jenab, M.
|b 37
700 1 _ |a Gunter, M.
|b 38
700 1 _ |a Agudo, A.
|b 39
773 _ _ |a 10.1002/ijc.32870
|g p. ijc.32870
|0 PERI:(DE-600)1474822-8
|n 4
|p 1027-1039
|t International journal of cancer
|v 147
|y 2020
|x 1097-0215
909 C O |o oai:inrepo02.dkfz.de:153166
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J CANCER : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J CANCER : 2017
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21